TRIM26 and hepatocellular carcinoma: Overexpression of TRIM26 inhibited HCC cell proliferation and migration via ubiquitination-dependent degradation of ZEB1 protein and thus impeded the epithelial-to-mesenchymal transition (EMT) process [25].